BN Business News
Add your company to Business Communicator →

Business · 10/16/2026

Sobi receives positive CHMP opinion for TRYNGOLZA® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Sobi has received a positive opinion from the CHMP for its treatment TRYNGOLZA® (olezarsen) for severe hypertriglyceridemia, based on Phase 3 CORE and CORE2 results.

Original source language: PR NewswireOpen original release →